Printer Friendly

PAUL ZOLL RECEIVES AMERICAN HEART ASSOCIATION LIFETIME ACHIEVEMENT AWARD FOR DEVELOPMENT OF CARDIAC PACEMAKER AND DEFIBRILLATOR

 PAUL ZOLL RECEIVES AMERICAN HEART ASSOCIATION LIFETIME ACHIEVEMENT
 AWARD FOR DEVELOPMENT OF CARDIAC PACEMAKER AND DEFIBRILLATOR
 WOBURN, Mass., Feb. 24 /PRNewswire/ -- Paul M. Zoll, M.D., Professor Emeritus, Harvard Medical School and a cardiologist at Boston's Beth Israel Hospital, is one of a select group of five physicians to receive the lifetime achievement award from the American Heart Association Sunday evening in Dallas. Zoll pioneered the use of electrical shock to stimulate the human heart in cardiac arrest. His research revolutionized cardiac care and led directtly to the development of temporary and permanent pacemakers and the external defibrillator -- technology responsible for saving countless thousands of lives.
 For over 40 years, Zoll has been a recognized leader in cardiac pacing, defibrillation (regulating heart beats), and monitoring. His early research provided the foundation from which many now familiar cardiac care technologies, disciplines, and instruments have evolved. These include such critical care innovations as pacemakers, defibrillators, cardiac monitors, the cardiac care unit itself, and the study of electrophysiology. In 1952, Zoll demonstrated that electrical stimulation to the surface of the chest during cardiac arrest produced (or regulated) effective heartbeats in humans. This research led to the development of noninvasive pacing, temporary endocardial pacing during surgery, and permanent implanted pacemakers.
 In 1956, Zoll was the first physician to successfully use external defibrillation to regulate erratic heart rhythms in patients suffering from heart disease or other cardiac conditions. During the 1960s and 1970s, Zoll's noninvasive pacing research continued, forging new ways to assure consistent, high quality performance, better patient tolerance during pacing, and increased efficacy.
 Zoll's present noninvasive pacing technology was introduced commercially in 1984 by Zoll Medical Corporation and is today considered the premier technology in the industry. It features a distinctive patented electrical pulse and redefined the industry standard with significantly enhanced success rates and broader patient application.
 Zoll's research and the ensuing development of innovative technologies continue to impact cardiology, increasing longevity of those suffering from heart disease. During the ceremony, the American Heart Association also honored Dr. Leonard Cobb, Dr. Steven Carveth, Dr. J. Frank Pantridge, Dr. Joseph Redding with lifetime cardiac-care awards. The presentation took place at the 1992 National Conference on Cardiopulmonary Resuscitation and Emergency Cardiac Care. The award represents the recipient's outstanding contributions to the areas of CPR and Emergency Cardiac Care.
 -0- 2/24/92 R
 /CONTACT: Ward Hamilton of Zoll Medical Corp., 617-933-9150, or 800-348-9011/ CO: Zoll Medical Corporation ST: Massachusetts IN: MTC SU:


DH -- NE001 -- 1895 02/24/92 12:21 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 24, 1992
Words:417
Previous Article:HILL AND KNOWLTON SURVEY: MAJORITY OF AMERICANS THINK MEDIA DOESN'T GIVE READERS AMPLE OPPORTUNITY TO DEFEND THEMSELVES
Next Article:HYBRID, MODULAR TECHNOLOGIES; HIGH-HEAT RESISTANT THERMOPLASTICS; ETCH- RESISTANT POLYURETHANE COATINGS; ENERGY ABSORBING POLYURETHANE FOAMS TO...
Topics:


Related Articles
LIFEPAK 11 DEFIBRILLATOR/PACEMAKER JOINS THE LIFEPAK FAMILY OF PRODUCTS
ZOLL MEDICAL REPORTS RECORD 2ND QTR. REVENUES.
Frost & Sullivan: Defibrillator Product Sales Set the Pace in Implantable Cardiac Rhythm Device Markets.
Running With Heart: Pacemakers and Other Heart Devices Enhance Quality of Life.
Medtronic Bestows 'Full Life Awards' at American Heart Association Annual Meeting.
Cardiac Science Sues Zoll for Patent Infringement.
HEALTH CANADA APPROVES ZOLL'S M SERIES CCT DEFILBRILLATOR.
ZOLL and Cardiac Science Settle Patent Infringement Lawsuit.
Public Health Initiative Uses PocketCPR to Help Improve Cardiac Arrest Survival Rates.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters